Author:Ilaria De Giovanni

Blogs, Rare diseases

Four considerations before collecting real-world data in your EAP

News, Rare diseases

Sciensus partners with Sentynl Therapeutics

Thought Leadership, Rare diseases

Launching successful patient support programs for rare disease patients across Europe

Blogs, Rare diseases

Orphan drugs: How to avoid costly stock losses in Europe 

Blogs, Rare diseases

Out-licensing vs partnering: Strategies for accessing Europe 

Blogs, Rare diseases

Is data drought holding back your orphan drug?

Thought Leadership, Rare diseases

Market access for orphan drugs in Switzerland: a guide for Biotechs

Thought Leadership, Cancer

The benefits of digitally collecting PROMs to study patient wellbeing.